Erste Asset Management’s Genmab GMAB Stock Holding History

Erste Asset Management’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12,000	Closed	-$383K	–	547
2023 Q4	$383K	Hold	12,000	–	–	0.01%	447
2023 Q3	$424K	Hold	12,000	–	–	0.01%	423
2023 Q2	$449K	Hold	12,000	–	–	0.01%	423
2023 Q1	$451K	Hold	12,000	–	–	0.01%	432
2022 Q4	$511K	Hold	12,000	–	–	0.01%	424
2022 Q3	$383K	Hold	12,000	–	–	0.01%	448
2022 Q2	$381K	Hold	12,000	–	–	0.01%	455
2022 Q1	$442K	Hold	12,000	–	–	0.01%	448
2021 Q4	$478K	Hold	12,000	–	–	0.01%	432
2021 Q3	$508K	Hold	12,000	–	–	0.01%	405
2021 Q2	$498K	Hold	12,000	–	–	0.01%	412
2021 Q1	$381K	Hold	12,000	–	–	0.01%	407
2020 Q4	$477K	Buy	+12,000	New	+$449K	0.01%	393

Other funds holding GMAB

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Erste Asset Management's GMAB Position: Q1 2024 in Review

Erste Asset Management sold out of Genmab (GMAB) in Q1 2024, closing a stake of 12,000 shares — an estimated $383K sold.

Erste Asset Management first reported a position in GMAB in Q4 2020 and held it in 13 quarters. The position peaked at $511K in Q4 2022. 227 funds tracked by Wall St. Rank hold GMAB as of Q1 2024.

Erste Asset Management reported no remaining Genmab position as of Q1 2024 after selling out during the quarter.
Erste Asset Management sold 12,000 Genmab shares in Q1 2024, an estimated $383K.
Erste Asset Management first reported a position in Genmab in Q4 2020 and held it in 13 quarters.
Erste Asset Management's Genmab position peaked at $511K in Q4 2022.
227 funds tracked by Wall St. Rank held Genmab as of Q1 2024.

Based on Erste Asset Management's 13F filing for Q1 2024, filed 26 Nov 2024.